Congenital Hyperinsulinism International (CHI) is a nonprofit 501(c)(3) corporation dedicated to improving the lives of babies, children, and adults affected by congenital hyperinsulinism (HI). HI is a life-threatening genetic disorder that causes severe low blood sugar (hypoglycemia) in infants and children, though in 50% of patients, the genetic cause is unknown. For those with HI, the beta cells of the pancreas secrete too much insulin in an unregulated manner. Excess insulin causes hypoglycemia. Prolonged or severe hypoglycemia can cause seizures, permanent brain damage, or even death if left untreated. A good prognosis is far more likely with a timely diagnosis and proper management.
Executive compensation
Form 990 · Schedule J · 3 reported individuals · Filing year 2024
| Base salary | Executive compensation | |
|---|---|---|
Cro officer (unspecified) $95k | ||
Plus 7 unpaid individuals.
Browse compensation in Diseases, Disorders & Medical Disciplines →
Up 10%
from 2023
From $104k in 2023 to $114k in 2024.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.